Dual manipulation, in line with the above results, achieved lowest CDK2 expressions (Figure 7D), confirming the involvement of HSP90AA1-IT1/miR-885-5p/CDK2 signaling in the development of gliomas. Here, HSP90AA1 is linked to central nervous system cancer.